Saturday 5th September

Saturday 5th September 2015

13:00 - 14:30

 

WONOEP Highlights

The WONOEP workshop, which traditionally takes place in the days before the International Epilepsy Congress, is a unique opportunity for basic scientists and clinicians to get together and appraise the latest developments in translational science.

Chairs:  Raman Sankar (USA), Katja Kobow (Germany) and Marco de Curtis (Italy)

  • Peripheral biomarkers.  Manisha Patel (USA)
  • Biomarkers of comorbidities.  Raman Sankar  (USA)
  • Biomarkers of brain damage and epileptogenesis. Ping Zheng (Australia)
  • Imaging biomarkers. Astrid Nahlig Nehlig (France)
  • Biomarkers at the cross with clinics. Pete Engel  (USA)

 

TEACHING SESSION:                                                                                                                                                 

SERIES 1: VIREPA: EEG IN THE DIAGNOSIS AND MANAGEMENT OF EPILEPSY IN ADULTS AND CHILDREN                

Chair: Monika M. Eisermann (France)

  • Speaker 1: Sándor Benicsky (Denmark)
  • Speaker 2: Monika M. Eisermann (France)

 

TEACHING SESSION:                                                                                                                                     

SERIES 2: CASE ORIENTED SERIES: SURGERY YES OR NO? CLINICAL DECISION MAKING IN PRACTICE                   

Chair: Serap Saygı (Turkey)

  • Speaker 1: Imad Najm (USA)
  • Speaker 2: Pavel  Kršek (Czech Republic)
  • Speaker 3:  Serap Saygı (Turkey)

 

TEACHING SESSION:                                                                                                                                     

SERIES 3: EPILEPSY IN THE TROPICS: UPDATE AND PERSPECTIVES: EPIDEMIOLOGY, TREATMENT GAP AND SPECIFIC TROPICAL ETIOLOGIES                                                                                                                                    

Chair: Amadou Gallo Diop (Senegal)

  • Epidemiology and etiology of epilepsy in the tropics - Shichuo Li (China)
  • The epilepsy treatment gap in tropical countries: understanding the causes, limitations and appropriate interventions - Amadou Gallo Diop (Senegal)
  • The neglected nervous system in the neglected tropical diseases - Esper Cavalheiro (Brazil)

 

17:00 - 18:30

PARALLEL SESSION:
EXPLORING NEW THERAPIES FOR HUMAN MONOGENIC EPILEPSIES USING PERSONALIZED MODELS  
                  

Chair: Nerses Bebek (Turkey)

  • Neonatal estradiol prevents infantile spasms and seizures in arx-linked infantile spasms syndrome - Jeffrey Noebels (USA)
  • Rescuing the effects of a potassium channel mutation associated with neonatal seizures – Hande Caglayan (Turkey)
  • Preventing generalised seizures in GABAA2 receptor mutations in infancy with triheptanoin dietary therapy - Steve Petrou (Australia)
  • Personalising treatment for Dravet Syndrome: Lessons from animal models and iPS cells - Kazuhiro Yamakawa (Japan)

 

PARALLEL SESSION:
UNDERSTANDING AND PREVENTING EPILEPSY-RELATED MORTALITY    
  

 

 

 

Chair: Naz Yeni (Turkey)

  • SUDEP: From understanding mechanisms to clinical prevention - Philippe Ryvlin (France)
  • Can the risk of SUDEP be predicted and quantified? - Alica Goldman (USA)​
  • SUDEP is not the only cause of death in epilepsy - Ley Sander (The Netherlands)
  • When and who to tell? A transcultural vision - Manuel Tomás Mesa (Chile)

 

PARALLEL SESSION:
ACUTE NEONATAL SEIZURES OR EARLY ONSET EPILEPSY? CHALLENGES OF EARLY RECOGNITION AND IMPLICATIONS FOR MANAGEMENT

Chair: Perrine Plouin (France)

  • Acute neonatal seizures - Geraldine Boylan (Ireland)
  • Neonatal onset genetic epilepsies - Maria Roberta Cilio (USA)
  • Neonatal seizures due to inborn errors of metabolism - Barbara Plecko (Switzerland)
  • From phenotype to classification - Ronit Pressler (UK)​

 

PARALLEL SESSION:
TERATOGENIC EFFECTS OF AEDS: WHERE ARE WE 50 YEARS AFTER THE FIRST REPORTS?

Co-Chairs: Kimford Meador (United States), Dina Battino (Italy)

  • Mechanisms of developmental toxicity of AEDs - Peter G. Wells (Canada)
  • Comparing risks of birth defects: What have we learnt from pregnancy registries? - Torbjörn Tomson (Sweden)​
  • Cognitive and behavioural outcomes after foetal exposure to different AEDs - Kimford J. Meador (USA)
  • Towards rational management of epilepsy in pregnancy: Improving foetal and maternal safety - Sanjeev V. Thomas (India)

 

PARALLEL SESSION:
PERSONALISING mTOR INHIBITION FOR EPILEPSY TREATMENT: FROM BENCH TO BEDSIDE

Co-Chairs: Zuhal Yapici (Turkey), Aristea Galanopoulou (United States)

  • mTORopathies and epilepsies - Eleonora Aronica (The Netherlands)
  • mTOR inhibitors in the treatment of epilepsies: Promises and pitfalls - Peter Crino (USA)
  • Anti-epilepsy therapies in the treatment of mTORopathies - Nail Burnashev (France)
  • Personalizing treatment of epilepsy in Tuberous Sclerosis Complex - Sergiusz Jozwiak (Poland)

 

19:00 - 20:00 

  • Welcome Ceremony (takes place in the "Andalou Hall" of the congress venue)

 

20:00 - 21:00

  • Welcome Reception (takes place on the "Rumeli Terrace" of the congress venue)